Variant report
Variant | nsv887694 |
---|---|
Chromosome Location | chr7:13680696-13718969 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ARL4A-7 | chr7:13710212-13710299 | NONHSAT119248 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6955325 | chr7:13680696-13680697 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs548342888 | chr7:13680739-13680740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374762853 | chr7:13680744-13680745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6955852 | chr7:13680745-13680746 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs547637370 | chr7:13680751-13680752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570734436 | chr7:13680756-13680757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145370727 | chr7:13680796-13680797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149215297 | chr7:13680809-13680810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569696016 | chr7:13680827-13680828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535524989 | chr7:13680893-13680894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555076042 | chr7:13680898-13680899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77926756 | chr7:13681118-13681119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541357028 | chr7:13681121-13681122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143416608 | chr7:13681131-13681132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577988900 | chr7:13681144-13681145 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543672208 | chr7:13681150-13681151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17167301 | chr7:13681154-13681155 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs576503135 | chr7:13681176-13681177 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182285494 | chr7:13681177-13681178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs386710533 | chr7:13681241-13681242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146408192 | chr7:13681254-13681255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140808545 | chr7:13681286-13681287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547701829 | chr7:13681301-13681302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561236520 | chr7:13681356-13681357 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564466530 | chr7:13681371-13681372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533441126 | chr7:13681379-13681380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550002382 | chr7:13681381-13681382 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570191024 | chr7:13681387-13681388 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535199433 | chr7:13681408-13681409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549032480 | chr7:13681421-13681422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574344822 | chr7:13681444-13681445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565553014 | chr7:13681495-13681496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10499434 | chr7:13681514-13681515 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs369301248 | chr7:13681553-13681554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs17589432 | chr7:13681581-13681582 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs187999284 | chr7:13681631-13681632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562922622 | chr7:13681647-13681648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112022811 | chr7:13681660-13681661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10499435 | chr7:13681671-13681672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573733472 | chr7:13681677-13681678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552337395 | chr7:13681681-13681682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541981275 | chr7:13681687-13681688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191910747 | chr7:13681691-13681692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183944078 | chr7:13681711-13681712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565949045 | chr7:13681732-13681733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531840315 | chr7:13681749-13681750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114490654 | chr7:13681753-13681754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533455284 | chr7:13681764-13681765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550402640 | chr7:13681829-13681830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs17589467 | chr7:13681848-13681849 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 17440070 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:13669000-13681400 | Weak transcription | NHDF-Ad | bronchial |
2 | chr7:13679600-13681400 | Weak transcription | Fetal Lung | lung |
3 | chr7:13681000-13681800 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr7:13681400-13681600 | Enhancers | NHDF-Ad | bronchial |
5 | chr7:13681400-13681800 | Enhancers | Fetal Lung | lung |
6 | chr7:13681400-13682000 | Enhancers | Osteobl | bone |
7 | chr7:13681600-13682400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr7:13687800-13688200 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr7:13687800-13688600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr7:13688000-13688400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr7:13688000-13688400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr7:13688000-13688600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr7:13688200-13688600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr7:13688600-13697600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr7:13696200-13697800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
16 | chr7:13696200-13698000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
17 | chr7:13697600-13698200 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
18 | chr7:13712600-13714800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr7:13713000-13713200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr7:13713000-13713200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr7:13713200-13717600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
22 | chr7:13713200-13719000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr7:13717200-13718200 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
24 | chr7:13717600-13718000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |